A breakthrough liver disease treatment, initially developed at the 国产探花, will begin clinical trials next year.
17 November 2016
The treatment involves swallowing a sachet containing tiny carbon beads that are designed to remove toxins produced by bacteria in the gut and stop them attacking the liver.
The 国产探花 jointly developed the patent for this technology with UCL and a industry partner, and is also a partner in the Carbalive Consortium, an international collaboration set up to establish the safety and efficacy of the novel oral carbon therapy.
You can read the full story published in .
TEF Silver awarded for the quality of our teaching and student outcomes
We are in the top 4.3% of institutions globally, Center for World University Rankings 2025
Race Equality Charter Silver awarded for our pledge to advance representation, progression and success for minority ethnic staff and students
We are ranked 14th in Stonewall's top 100 employers for commitment to equality for LGBTQ+ staff and students
We were awarded Athena Swan Silver for advancement of gender equality, representation, progression and success for all
We are a Disability Confident employer, committed to ensuring opportunity for progression for all
Signed to the Disabled Student Commitment, an initiative to improve support for disabled students
EcoCampus Platinum accredited for our environmental sustainability, compliance and processes
